|
US6548490B1
(en)
|
1997-10-28 |
2003-04-15 |
Vivus, Inc. |
Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
|
|
GB0008694D0
(en)
*
|
2000-04-07 |
2000-05-31 |
Novartis Ag |
Organic compounds
|
|
US20030032579A1
(en)
|
2001-04-20 |
2003-02-13 |
Pfizer Inc. |
Therapeutic use of selective PDE10 inhibitors
|
|
DE10130167A1
(de)
|
2001-06-22 |
2003-01-02 |
Bayer Ag |
Imidazotriazine
|
|
WO2003014116A1
(en)
|
2001-08-06 |
2003-02-20 |
Bayer Corporation |
Pyrrolo[2.1-a]isoquinoline derivatives
|
|
US20030114469A1
(en)
*
|
2001-09-27 |
2003-06-19 |
Cohen David Saul |
Combinations
|
|
JPWO2004002484A1
(ja)
|
2002-06-26 |
2005-10-27 |
協和醗酵工業株式会社 |
ホスホジエステラーゼ阻害剤
|
|
DE10230605A1
(de)
|
2002-07-08 |
2004-01-29 |
Bayer Ag |
Substituierte Imidazotriazine
|
|
DE10230604A1
(de)
|
2002-07-08 |
2004-01-29 |
Bayer Ag |
Heterocyclisch substituierte Imidazotriazine
|
|
WO2005002579A1
(en)
|
2003-06-30 |
2005-01-13 |
Altana Pharma Ag |
Pyrrolo-dihydroisoquinoline derivatives as pde10 inhibitors
|
|
WO2005003129A1
(en)
|
2003-06-30 |
2005-01-13 |
Altana Pharma Ag |
Pyrrolodihydroisoquinolines as pde10 inhibitors
|
|
JP2007508241A
(ja)
|
2003-07-31 |
2007-04-05 |
バイエル・フアーマシユーチカルズ・コーポレーシヨン |
Ｐｄｅ１０ａ阻害剤を用いる糖尿病および関連障害の処置方法
|
|
EP1723134A2
(en)
|
2004-02-18 |
2006-11-22 |
Pfizer Products Incorporated |
Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
|
|
JP2008501776A
(ja)
|
2004-06-07 |
2008-01-24 |
ファイザー・プロダクツ・インク |
肥満に関連し、かつメタボリックシンドロームに関連する状態の治療としてのホスホジエステラーゼ１０の阻害
|
|
US20060019975A1
(en)
|
2004-07-23 |
2006-01-26 |
Pfizer Inc |
Novel piperidyl derivatives of quinazoline and isoquinoline
|
|
AU2005282721A1
(en)
|
2004-09-03 |
2006-03-16 |
Memory Pharmaceuticals Corporation |
4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
|
|
WO2006034512A2
(en)
|
2004-09-23 |
2006-03-30 |
Bayer Pharmaceuticals Corporation |
Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
|
|
US7576080B2
(en)
|
2004-12-23 |
2009-08-18 |
Memory Pharmaceuticals Corporation |
Certain thienopyrimidine derivatives as phosphodiesterase 10 inhibitors
|
|
US20060183763A1
(en)
|
2004-12-31 |
2006-08-17 |
Pfizer Inc |
Novel pyrrolidyl derivatives of heteroaromatic compounds
|
|
CN102491969B
(zh)
|
2005-01-07 |
2015-08-19 |
辉瑞产品公司 |
杂芳族喹啉化合物及其作为pde10抑制剂的用途
|
|
WO2006075012A2
(en)
|
2005-01-12 |
2006-07-20 |
Nycomed Gmbh |
Pyrrolodihydroisoquinolines as antiproliferative agents
|
|
WO2006089815A1
(en)
|
2005-01-12 |
2006-08-31 |
Nycomed Gmbh |
Novel pyrrolodihydroisoquinolines as pde10 inhibitors
|
|
AU2006279548A1
(en)
|
2005-08-16 |
2007-02-22 |
Amgen, Inc. |
Phosphodiesterase 10 inhibitors
|
|
CA2635439A1
(en)
|
2006-01-27 |
2007-08-02 |
Pfizer Products Inc. |
Aminophthalazine derivative compounds
|
|
WO2007098169A1
(en)
|
2006-02-21 |
2007-08-30 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
EP1991540A1
(en)
|
2006-02-21 |
2008-11-19 |
Amgen Inc. |
Cinnoline derivatives as phosphodiesterase 10 inhibitors
|
|
CA2641670A1
(en)
|
2006-02-23 |
2007-08-30 |
Pfizer Products Inc. |
Substituted quinazolines as pde10 inhibitors
|
|
EP1991531A1
(en)
|
2006-02-28 |
2008-11-19 |
Amgen Inc. |
Cinnoline and quinoxaline derivates as phosphodiesterase 10 inhibitors
|
|
US20090099175A1
(en)
|
2006-03-01 |
2009-04-16 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
|
US20070265258A1
(en)
|
2006-03-06 |
2007-11-15 |
Ruiping Liu |
Quinazoline derivatives as phosphodiesterase 10 inhibitors
|
|
CA2644850A1
(en)
|
2006-03-08 |
2007-09-13 |
Amgen Inc. |
Quinoline and isoquinoline derivatives as phosphodiesterase 10 inhibitors
|
|
TW200815436A
(en)
|
2006-05-30 |
2008-04-01 |
Elbion Ag |
4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
TW200817400A
(en)
|
2006-05-30 |
2008-04-16 |
Elbion Ag |
Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
|
|
US20080090834A1
(en)
|
2006-07-06 |
2008-04-17 |
Pfizer Inc |
Selective azole pde10a inhibitor compounds
|
|
SI2057153T1
(sl)
|
2006-07-10 |
2012-12-31 |
H. Lundbeck A/S |
(3-ril-piperazin-1-il) derivati 6,7-dialkoksikuinazolin, 6,7-dialkoksiftalazin in 6,7-dialkoksiizokuinolin
|
|
WO2008020302A2
(en)
|
2006-08-17 |
2008-02-21 |
Pfizer Products Inc. |
Heteroaromatic quinoline-based compounds as phosphodiesterase (pde) inhibitors
|
|
CN101573348A
(zh)
|
2006-09-11 |
2009-11-04 |
矩阵实验室有限公司 |
作为pde-4和pde-10的抑制剂的二苯并呋喃衍生物
|
|
CN101166128A
(zh)
|
2006-10-16 |
2008-04-23 |
琥珀技术有限公司 |
一种提供第三方服务的方法及相应的系统
|
|
WO2008064342A2
(en)
|
2006-11-21 |
2008-05-29 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
US7786139B2
(en)
|
2006-11-21 |
2010-08-31 |
Omeros Corporation |
PDE10 inhibitors and related compositions and methods
|
|
WO2009025823A1
(en)
|
2007-08-21 |
2009-02-26 |
Amgen Inc. |
Phosphodiesterase 10 inhibitors
|
|
WO2009025839A2
(en)
|
2007-08-22 |
2009-02-26 |
Amgen Inc. |
Phosphodiesterase 10 inhibitors
|
|
US20090054434A1
(en)
|
2007-08-23 |
2009-02-26 |
Amgen Inc. |
Isoquinolone derivatives as phosphodiesterase 10 inhibitors
|
|
TW200918519A
(en)
*
|
2007-09-19 |
2009-05-01 |
Lundbeck & Co As H |
Cyanoisoquinoline
|
|
CN101918408A
(zh)
|
2007-11-30 |
2010-12-15 |
惠氏有限责任公司 |
作为磷酸二酯酶10的抑制剂的芳基和杂芳基稠合的咪唑并[1,5-a]吡嗪
|
|
WO2009070583A1
(en)
|
2007-11-30 |
2009-06-04 |
Wyeth |
Pyrido[3,2-e]pyrazines, process for preparing the same, and their use as inhibitors of phosphodiesterase 10
|
|
US20090143391A1
(en)
|
2007-11-30 |
2009-06-04 |
Norbert Hofgen |
Aryl and heteroaryl fused imidazo [1,5-a] pyrazines as inhibitors of phosphodiesterase 10
|
|
WO2009143178A2
(en)
|
2008-05-20 |
2009-11-26 |
Omeros Corporation |
Pde10 inhibitors and related compositions and methods
|
|
US8133897B2
(en)
|
2008-06-20 |
2012-03-13 |
H. Lundbeck A/S |
Phenylimidazole derivatives as PDE10A enzyme inhibitors
|
|
UA102693C2
(ru)
|
2008-06-20 |
2013-08-12 |
Х. Луннбек А/С |
Производные фенилимидазола как ингибиторы фермента pde10a
|
|
TWI501965B
(zh)
|
2008-06-20 |
2015-10-01 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之新穎苯基咪唑衍生物
|
|
US20110224204A1
(en)
|
2008-06-25 |
2011-09-15 |
Richard Chesworth |
Di-substituted phenyl compounds
|
|
CN102131801B
(zh)
|
2008-06-25 |
2015-04-08 |
福拉姆医药股份有限公司 |
1,2-二取代的杂环化合物
|
|
US8481532B2
(en)
|
2008-07-09 |
2013-07-09 |
Envivo Pharmaceuticals, Inc. |
PDE-10 inhibitors
|
|
ES2654617T3
(es)
|
2008-08-05 |
2018-02-14 |
Omeros Corporation |
Inhibidores de PDE10 y composiciones y procedimientos relacionados
|
|
JP5290406B2
(ja)
|
2008-09-04 |
2013-09-18 |
田辺三菱製薬株式会社 |
三置換ピリミジン化合物及びそのｐｄｅ１０阻害薬としての使用
|
|
JP2012506873A
(ja)
|
2008-10-28 |
2012-03-22 |
シェーリング コーポレイション |
置換ピラゾロキノリンおよびそれらの誘導体
|
|
US20100120763A1
(en)
|
2008-11-07 |
2010-05-13 |
Wyeth |
Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases
|
|
US20100120762A1
(en)
|
2008-11-07 |
2010-05-13 |
Wyeth |
Triazine derivatives as inhibitors of phosphodiesterases
|
|
AR074343A1
(es)
|
2008-11-14 |
2011-01-12 |
Amgen Inc |
Derivados de piridina y pirimidina como inhibidores de la fosfodiesterasa 10
|
|
AU2009321601B2
(en)
|
2008-12-04 |
2012-11-01 |
F. Hoffmann-La Roche Ag |
Pyridazinone derivatives
|
|
WO2010077992A1
(en)
|
2008-12-17 |
2010-07-08 |
Amgen Inc. |
Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
|
|
ME02337B
(me)
|
2009-02-05 |
2016-06-20 |
Takeda Pharmaceuticals Co |
Jedinjenja piridazinona
|
|
US9187455B2
(en)
|
2009-02-23 |
2015-11-17 |
Hoffmann-La Roche Inc. |
Substituted pyridazines as PDE10A inhibitors
|
|
WO2010097367A1
(en)
|
2009-02-24 |
2010-09-02 |
Janssen Pharmaceutica Nv |
Radiolabelled pde10 ligands
|
|
US8685967B2
(en)
|
2009-04-07 |
2014-04-01 |
Merck Sharp & Dohme Corp. |
Substituted triazolopyridines and analogs thereof
|
|
PL2617420T3
(pl)
|
2009-05-07 |
2016-04-29 |
Forum Pharmaceuticals Inc |
Heterocykliczne związki fenoksymetylu
|
|
EP2434885B1
(en)
|
2009-05-27 |
2014-03-26 |
Merck Sharp & Dohme Corp. |
Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
|
|
WO2010138585A1
(en)
|
2009-05-29 |
2010-12-02 |
Merck Sharp & Dohme Corp. |
Pyrimidinones as pde10 inhibitors
|
|
JP5718323B2
(ja)
|
2009-05-29 |
2015-05-13 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
放射標識されたｐｄｅ１０阻害剤
|
|
TW201111383A
(en)
|
2009-05-29 |
2011-04-01 |
Wyeth Llc |
Substituted imidazo[1,5-a]quinoxalines as inhibitors of phosphodiesterase 10
|
|
EP2467382B1
(en)
|
2009-08-17 |
2014-06-25 |
Merck Sharp & Dohme Corp. |
Amino tetrahydro-pyridopyrimidine pde10 inhibitors
|
|
PL2480546T3
(pl)
|
2009-09-24 |
2015-05-29 |
Hoffmann La Roche |
Pochodne imidazopirydyny i imidazopirymidyny jako inhibitory fosfodiesterazy 10A
|
|
EP2493308A4
(en)
|
2009-10-30 |
2013-05-15 |
Merck Sharp & Dohme |
ARYLAMINOPYRIDIN PDE10 INHIBITORS
|
|
AU2010311511B2
(en)
|
2009-10-30 |
2014-07-17 |
Janssen Pharmaceutica Nv |
Imidazo[1,2-b]pyridazine derivatives and their use as PDE10 inhibitors
|
|
JP5778164B2
(ja)
|
2009-10-30 |
2015-09-16 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプＪａｎｓｓｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａ Ｎａａｍｌｏｚｅ Ｖｅｎｎｏｏｔｓｃｈａｐ |
放射標識ｐｄｅ１０リガンド
|
|
TWI487705B
(zh)
|
2009-12-17 |
2015-06-11 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基三唑衍生物
|
|
TWI481607B
(zh)
|
2009-12-17 |
2015-04-21 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物
|
|
TWI485151B
(zh)
|
2009-12-17 |
2015-05-21 |
Lundbeck & Co As H |
作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族苯基咪唑衍生物
|
|
TW201200516A
(en)
|
2009-12-17 |
2012-01-01 |
Lundbeck & Co As H |
Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors
|
|
US8470820B2
(en)
|
2010-01-22 |
2013-06-25 |
Hoffman-La Roche Inc. |
Nitrogen-containing heteroaryl derivatives
|
|
CA2791166C
(en)
|
2010-02-26 |
2014-12-30 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolopyrimidine compounds and their use as pde10 inhibitors
|
|
JP2011201873A
(ja)
|
2010-03-03 |
2011-10-13 |
Mitsubishi Tanabe Pharma Corp |
三置換ピリミジン化合物及びそのｐｄｅ１０阻害薬としての使用
|
|
AR080754A1
(es)
|
2010-03-09 |
2012-05-09 |
Janssen Pharmaceutica Nv |
Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
|
|
ES2742195T3
(es)
|
2010-03-12 |
2020-02-13 |
Omeros Corp |
Inhibidores de PDE10 y composiciones y métodos relacionados
|
|
US8410117B2
(en)
|
2010-03-26 |
2013-04-02 |
Hoffmann-La Roche Inc. |
Imidazopyrimidine derivatives
|
|
WO2011132048A1
(en)
|
2010-04-19 |
2011-10-27 |
Glenmark Pharmaceutical S.A. |
Heteroaryl compounds as pde10a inhibitors
|
|
WO2011132051A2
(en)
|
2010-04-19 |
2011-10-27 |
Glenmark Pharmaceuticals S.A. |
Tricycle compounds as phosphodiesterase-10 inhibitors
|
|
WO2011138657A1
(en)
|
2010-05-04 |
2011-11-10 |
Glenmark Pharmaceuticals S.A. |
Aryl substituted olefinic compounds as pde10a inhibitors
|
|
JP2013526546A
(ja)
|
2010-05-13 |
2013-06-24 |
アムジエン・インコーポレーテツド |
Ｐｄｅ１０阻害剤としてのヘテロアリ−ルオキシヘテロシクリル化合物
|
|
AU2011253058A1
(en)
|
2010-05-13 |
2012-12-06 |
Amgen Inc. |
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
|
|
MA34300B1
(fr)
|
2010-05-13 |
2013-06-01 |
Amgen Inc |
Composés azotés hétérocycliques convenant comme inhibiteurs de la pde10
|
|
EP3318561B1
(en)
|
2010-05-26 |
2021-12-22 |
Sunovion Pharmaceuticals Inc. |
Heteroaryl compounds and methods of use thereof
|
|
US8703768B2
(en)
|
2010-06-09 |
2014-04-22 |
Hoffmann-La Roche Inc. |
Nitrogen containing heteroaryl compounds
|
|
US8846713B2
(en)
|
2010-06-24 |
2014-09-30 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
|
|
TW201215607A
(en)
|
2010-07-02 |
2012-04-16 |
Lundbeck & Co As H |
Aryl-and heteroarylamid derivatives as PDE10A enzyme inhibitor
|
|
TW201206935A
(en)
|
2010-07-16 |
2012-02-16 |
Lundbeck & Co As H |
Triazolo-and pyrazoloquinazoline derivatives as PDE10A enzyme inhibitor
|
|
MX2013009575A
(es)
*
|
2011-02-18 |
2014-10-14 |
Exonhit Therapeutics Sa |
Derivados de 6, 7-dialcoxi-3-isoquinolinol sustituidos como inhibidores de fosfodiesterasa 10 (pdei0a).
|
|
US9200016B2
(en)
*
|
2013-12-05 |
2015-12-01 |
Allergan, Inc. |
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
|